DigitalHealth.London Spotlight: Neu Health

Parkinson’s Awareness Week is an annual campaign that aims to raise awareness and fundraise for research. For 2025, World Parkinson’s Day falls on Friday 11 April, marking the birthday of James Parkinson (1755-1824). The English surgeon’s pioneering ‘Essay on the Shaking Palsy’ (1817) is credited as providing the first definition of Parkinson’s, leading to it being recognised as a medical condition, as well as encouraging research of its case, progression and treatment.

To mark the awareness day, we’re shining the DigitalHealth.London spotlight on Neu Health. The Accelerator company shares how their AI-powered remote monitoring solution is aiming to enhance care to empower people living with Parkinson’s and dementia.

What is the problem you are trying to solve and why is it important?  

Over the last 30 years, the number of people living with neurological conditions has risen sharply, affecting 43% of the global population. These neurological conditions cost healthcare systems billions annually, and factors including a growing global population, higher life expectancy, and environmental and lifestyle factors are set to increase the strain on patients, their families and clinicians.

In the UK, for example, 153,000 people live with Parkinson’s, whilst a further 982,000 people are affected by dementia. By 2050, this is set to rise to 307,000 and 1.7 million respectively – a trend that is mirrored globally, with Parkinson’s estimated to reach over 25 million cases and dementia set to triple to 153 million.

Yet care often remains fragmented, reactive and reliant on subjective assessments. Neu Health is aiming to tackle this by enabling data-driven, AI-powered remote monitoring to enhance care quality and efficiency for people living with Parkinson’s and dementia.

What is the solution you have developed and how can it help with the problem? 

Neu Health has developed a smartphone-based Software as a Medical Device (SaMD) that transforms everyday smartphones into a clinically validated neurology assessment tool. Powered by AI and built on over 10 years of research from Oxford University and the world’s largest longitudinal Parkinson’s dataset, our technology remotely monitors over 30 motor, non-motor and cognitive symptoms through objective assessments and self-reported measures. These include balance, gait and voice, as well as cognitive processing, freezing episodes and sleep.

Multidisciplinary Teams (MDTs) involved with a patient’s care receive real-time, objective insights via our dashboard. This enables earlier interventions, personalised treatment, and improved efficiency.

By integrating into existing healthcare pathways, our solution has the potential to reduce the burden on overstretched neurology services, enhance patient engagement and align with policy shifts like the US GUIDE initiative and UK elective care reforms to scale digital-first neurology care.

This week is Parkinson’s Awareness Week, with World Parkinson’s Day on Friday 11 April. Why is this campaign important to be aware of and how does your work contribute to its goals? 

Parkinson’s Awareness Week highlights the urgency of improving care for the 10 million people globally affected by the condition. With Parkinson’s cases projected to grow significantly, early intervention and continuous monitoring are critical.

Neu Health directly supports this mission by providing AI-powered, smartphone-based remote monitoring that enables clinicians to make informed, timely treatment decisions. By empowering patients and healthcare professionals with objective, real-time data, we are accelerating progress towards more personalised, proactive approach to Parkinson’s care.

What’s the history of your company? 

Neu Health is a University of Oxford spinout, founded by Dr Kinan Muhammed and Caroline Cake in 2023 to transform neurology care with AI-powered digital tools.

Co-Founder and Chief Medical Officer, Kinan, is a leading Oxford neurologist who is driven to transform neurology, not just for his patients but for all. Co-Founder and CEO, Caroline, was inspired by both her professional background and personal experience of seeing her mother and grandmother navigate dementia with limited support.

She previously worked at the forefront of data-driven innovation during COVID-19 at the National Institute for Health Data Science (HDR UK) and recognised the potential to bring this level of digital transformation to neurology.

What successes have you had so far from successful pilots/trials/contracts? 

• Clinical Validation: Over 1,000 patients onboarded, 400,000+ digital measures collected.
• Improved Clinical Outcomes: 90% of neurology appointments led to better treatment decisions.
• Efficiency Gains: 31% reduction in neurology resource use, 20% increase in visit efficiency.
• User Satisfaction: 100% of clinicians found the platform useful; 83% of patients found it easy to use.
• Global Expansion: Contracts with 7 NHS hospitals, Cedars-Sinai, and MGB, with further US hospital partnerships in progress.
• Award Recognition: Winners of the NHS HSJ National Award for Digitising Patient Care (2024).

How has your time on the DigitalHealth.London Accelerator so far helped you in achieving these? 

The DigitalHealth.London Accelerator has supported Neu Health’s growth, providing strategic connections, regulatory guidance, and commercial expertise. Through the programme, we have expanded our engagement with key healthcare decision-makers. The Accelerator has helped us refine our NHS market strategy, navigate procurement processes, and understand reimbursement structures to speed up adoption.

Additionally, access to industry mentors and investor networks has strengthened our commercial positioning and investment readiness. The credibility of being part of DigitalHealth.London has bolstered our ability to form collaborations, scale within NHS pathways, and position Neu Health as a leader in digital neurology.

What are your future goals? What does success look like? 

• Transforming Neurology Care: Shifting from reactive, episodic care to proactive, data-driven management, ensuring people with Parkinson’s and dementia receive timely interventions that improve outcomes and quality of life.
• Empowering People with Neurological Conditions: Enabling individuals to actively manage their condition, stay independent for longer, and live well through personalised, accessible digital health solutions.
• Supporting Healthcare Systems: Helping healthcare providers deliver the care people deserve by improving efficiency, reducing burden, and integrating better decision-making tools into existing workflows.
• Scaling in the UK and US: Expanding our partnerships with healthcare providers, payers, and research institutions to drive adoption across key markets.
• Driving Evidence and Innovation: Continuously advancing our platform to enhance real-world impact and set new standards in neurology care.

Do you have any advice for aspiring digital health companies? 

• Validate clinically and commercially: Secure strong clinical validation and market need evidence early.
• Engage with healthcare providers early: Understand NHS and US hospital procurement pathways from the start.
• Prioritise regulatory and reimbursement strategy: Success depends on reimbursement, approvals, and compliance.
• Ensure seamless integration: Digital health tools must work with existing EHR systems and workflows.
• Build for global scale: Develop scalable solutions with clear pathways for international adoption.

We are seeking NHS Trusts, US healthcare providers, and investors interested in transforming neurology care. If you are a clinician, policymaker, or healthcare leader exploring transformation of neurology care, we’d love to connect. Let’s collaborate to advance digital neurology solutions and improve patient outcomes worldwide.

For more information, please get in touch: neu.health | LinkedIn

Neu Health is on Cohort 8 of the DigitalHealth.London Accelerator programme.

The DigitalHealth.London Accelerator programme is funded by the UK Government via the UK Shared Prosperity Fund (UKSPF). It is delivered by the Health Innovation Network (HIN) South London in partnership with the Office of Life Sciences, CW+, Medicity, NHS England, the Mayor of London and the Levelling Up Fund.

For more information, please visit https://www.gov.uk/government/publications/uk-
shared-prosperity-fund-prospectus.